| |
 |
|
Class Information
Number: 530/388.8
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. > Globulins > Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed > Monoclonal > Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) > Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a cancer cell, or with a substance shed or secreted by a cancer cell.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625859 |
HER-2 binding antagonists |
Dec. 1, 2009 |
| 7615216 |
Antibodies against CCR5 and uses thereof |
Nov. 10, 2009 |
| 7615372 |
Antibodies with immune effector activity and that internalize in endosialin-positive cells |
Nov. 10, 2009 |
| 7611706 |
RG1 antibodies and uses thereof |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7608263 |
RG1 antibodies and uses thereof |
Oct. 27, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7604799 |
EphA4 Antibodies |
Oct. 20, 2009 |
| 7595379 |
Antibodies and related molecules that bind to PSCA proteins |
Sep. 29, 2009 |
| 7595380 |
Monoclonal antibodies and methods for their use in the detection of cervical disease |
Sep. 29, 2009 |
| 7589180 |
Specific binding proteins and uses thereof |
Sep. 15, 2009 |
| 7589181 |
Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use |
Sep. 15, 2009 |
| 7585953 |
Antibodies specific for TAT285-1 |
Sep. 8, 2009 |
| 7575922 |
Polypeptide and gene encoding the same |
Aug. 18, 2009 |
| 7572897 |
Antibodies against insulin-like growth factor I receptor and uses thereof |
Aug. 11, 2009 |
| 7572895 |
Transferrin receptor antibodies |
Aug. 11, 2009 |
| 7572442 |
Selected antibody compositions for binding to aminophospholipids |
Aug. 11, 2009 |
| 7569674 |
Autophilic antibodies |
Aug. 4, 2009 |
| 7569673 |
Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
Aug. 4, 2009 |
| 7569356 |
Diagnosis and therapy of cancer using SGP28-related molecules |
Aug. 4, 2009 |
| 7563882 |
Polynucleotides encoding antibodies that bind to the C35 polypeptide |
Jul. 21, 2009 |
| 7563439 |
Production and use of novel peptide-based agents for use with bi-specific antibodies |
Jul. 21, 2009 |
| 7560111 |
HER2 antibody composition |
Jul. 14, 2009 |
| 7557189 |
Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
Jul. 7, 2009 |
| 7550143 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
Jun. 23, 2009 |
| 7547768 |
Anti-TAT 113 antibodies |
Jun. 16, 2009 |
| 7547544 |
Antibodies against GPR64 and uses thereof |
Jun. 16, 2009 |
| 7541160 |
ELISA for VEGF |
Jun. 2, 2009 |
| 7541437 |
Breast cancer resistance protein (BCRP) and the DNA which encode it |
Jun. 2, 2009 |
| 7541442 |
Antibodies and related molecules that bind to PSCA proteins |
Jun. 2, 2009 |
| 7538195 |
Anti-IGF-I receptor antibody |
May. 26, 2009 |
| 7534431 |
Methods and compositions for administering therapeutic and diagnostic agents |
May. 19, 2009 |
| 7531643 |
Monoclonal antibody inducing apoptosis |
May. 12, 2009 |
| 7527786 |
Methods for inhibiting the growth of cancer cells expressing PSCA |
May. 5, 2009 |
| 7524498 |
Human immunomodulatory monoclonal antibodies for the treatment of cancer |
Apr. 28, 2009 |
| 7521047 |
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
Apr. 21, 2009 |
| 7521542 |
Humanized Fc.gamma.RIIB-specific antibodies and methods of use thereof |
Apr. 21, 2009 |
| 7521543 |
A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same |
Apr. 21, 2009 |
| 7517663 |
Rabbit monoclonal antibody against Id1 protein |
Apr. 14, 2009 |
| 7517964 |
RS7 antibodies |
Apr. 14, 2009 |
| 7517967 |
Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
Apr. 14, 2009 |
| 7514221 |
Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
Apr. 7, 2009 |
| 7514538 |
Compositions and methods for the diagnosis and treatment of tumor |
Apr. 7, 2009 |
| 7511123 |
Immuno-interactive fragments of the alpha-C subunit of inhibin |
Mar. 31, 2009 |
| 7494648 |
Cancerous disease modifying antibodies |
Feb. 24, 2009 |
| 7495081 |
Framework patched anti-CD20 antibody |
Feb. 24, 2009 |
| 7495083 |
PRO940 antibodies |
Feb. 24, 2009 |
| 7491801 |
Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
Feb. 17, 2009 |
| 7491514 |
Reducing the immunogenicity of anti-CD20 antibodies by framework patching |
Feb. 17, 2009 |
| 7491700 |
Conversion of apoptotic proteins |
Feb. 17, 2009 |
|
|
|